Market Overview

UPDATE: Morgan Stanley Reiterates On athenahealth Following HQ Visit

Related ATHN
Women's Health USA Selects athenahealth To Connect Care
Urban Outfitters Drops On Q4 Profit Warning; Mead Johnson Nutrition Shares Spike Higher

In a report published Tuesday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Overweight rating on athenahealth (NASDAQ: ATHN), but removed the $192.00 price target.

In the report, Morgan Stanley noted, “Margins [are] in focus. Management goal is to achieve annual gross margin expansion as existing products gain critical mass and new services are launched. Collector margins are already at mid-70% range, representing a proxy for gross margin expansion opportunity as product suite reaches critical mass. Adjusting for R&D and S&M growth initiatives and gross margin expansion points to long-term steady state operating margin opportunity of 30%.”

athenahealth closed on Monday at $121.07.

Latest Ratings for ATHN

DateFirmActionFromTo
Dec 2014CitigroupMaintainsBuy
Dec 2014JP MorganMaintainsOverweight
Oct 2014BarclaysMaintainsEqual-weight

View More Analyst Ratings for ATHN
View the Latest Analyst Ratings

Posted-In: Morgan Stanley Ricky R. GoldwasserAnalyst Color Price Target Analyst Ratings

 

Related Articles (ATHN)

Around the Web, We're Loving...

Get Benzinga's Newsletters